- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.63 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x Y88: 6-[4-({4-[(2R)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile(Non-covalent)
- 2 x Y99: 6-[4-({4-[(2S)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile(Non-covalent)
Y99.2: 23 residues within 4Å:- Chain A: E.146, V.202, S.203, R.215, T.217, G.218, T.219
- Chain B: V.258, I.261, Y.262, Y.266, L.271, V.276, A.277, N.307, G.310, S.311, R.314, A.345, L.346, W.349
- Ligands: Y88.1, ANP.3
10 PLIP interactions:6 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:V.258, B:I.261, B:L.271, B:A.345
- Hydrogen bonds: B:R.314, A:R.215, A:R.215
- pi-Stacking: B:W.349
- pi-Cation interactions: A:R.215
- Halogen bonds: A:R.215
Y99.6: 23 residues within 4Å:- Chain A: V.258, I.261, Y.262, Y.266, L.271, V.276, A.277, N.307, G.310, S.311, R.314, A.345, L.346, W.349
- Chain B: E.146, V.202, S.203, R.215, T.217, G.218, T.219
- Ligands: Y88.5, ANP.7
10 PLIP interactions:6 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:V.258, A:I.261, A:L.271, A:A.345
- Hydrogen bonds: A:R.314, B:R.215, B:R.215
- pi-Stacking: A:W.349
- pi-Cation interactions: B:R.215
- Halogen bonds: B:R.215
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
ANP.3: 22 residues within 4Å:- Chain A: G.27, G.28, T.29, L.30, K.32, E.146, I.198, G.199, S.200, G.201, G.223, G.224, F.239, E.240, G.329, N.330, F.331, R.333
- Chain B: I.261
- Ligands: Y88.1, Y99.2, MG.4
25 PLIP interactions:25 interactions with chain A- Hydrogen bonds: A:G.28, A:T.29, A:L.30, A:L.30, A:K.32, A:R.94, A:G.199, A:S.200, A:G.201, A:G.223, A:E.240, A:N.330, A:N.330, A:F.331, A:R.333
- Water bridges: A:K.32, A:K.32, A:E.146, A:N.197, A:N.197, A:N.197, A:G.199, A:R.333
- Salt bridges: A:K.32
- pi-Stacking: A:F.239
ANP.7: 22 residues within 4Å:- Chain A: I.261
- Chain B: G.27, G.28, T.29, L.30, K.32, E.146, I.198, G.199, S.200, G.201, G.223, G.224, F.239, E.240, G.329, N.330, F.331, R.333
- Ligands: Y88.5, Y99.6, MG.8
26 PLIP interactions:26 interactions with chain B- Hydrogen bonds: B:G.28, B:T.29, B:L.30, B:L.30, B:K.32, B:R.94, B:G.199, B:S.200, B:G.201, B:G.223, B:E.240, B:N.330, B:N.330, B:F.331, B:R.333
- Water bridges: B:T.29, B:K.32, B:K.32, B:E.146, B:N.197, B:N.197, B:N.197, B:G.199, B:R.333
- Salt bridges: B:K.32
- pi-Stacking: B:F.239
- 2 x MG: MAGNESIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tangallapally, R. et al., Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem. (2024)
- Release Date
- 2023-03-29
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.63 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x Y88: 6-[4-({4-[(2R)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile(Non-covalent)
- 2 x Y99: 6-[4-({4-[(2S)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile(Non-covalent)
- 2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tangallapally, R. et al., Development of Brain Penetrant Pyridazine Pantothenate Kinase Activators. J.Med.Chem. (2024)
- Release Date
- 2023-03-29
- Peptides
- Pantothenate kinase 3: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A